Ashanda Esdaille

University of Wisconsin Health

Papers

1

Total Citations

3

H-Index

1

About

Dr. Ashanda Esdaille is a surgical oncologist whose research centers on optimizing outcomes for patients with advanced kidney cancer, particularly those undergoing cytoreductive nephrectomy (CN). Her major contribution lies in providing contemporary, multi-institutional data on peri-operative morbidity and mortality in this high-risk population. In her landmark 2021 study, which has garnered significant attention, Dr. Esdaille analyzed outcomes across five major centers, identifying key factors associated with surgical complications and 90-day mortality. This work fills a critical gap in the literature, offering evidence-based benchmarks that help clinicians better counsel patients with metastatic renal cell carcinoma (mRCC) considering CN. By moving beyond single-institution reports, her research provides a more reliable framework for risk stratification and shared decision-making. Dr. Esdaille’s efforts have been recognized as essential for modernizing surgical practice in an era of evolving systemic therapies, and her findings continue to influence treatment algorithms and preoperative planning. Her dedication to improving surgical safety and patient selection marks her as a rising leader in urologic oncology.

Research Focus

Key Achievements

1
H-Index
1
Papers
3
Total Citations
3
Avg Citations/Paper
🏆 Most Cited Paper
Peri-operative morbidity and mortality in a modern series of patients treated with cytoreductive nephrectomy (CN) at five centers.
3 citations · 2021
📈 Most Prolific Year: 2021 (1 Papers)
🤝 Key Collaborators: 12
🏛 Institutions: University of Wisconsin Health

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 11 days ago